3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Ovarian High Grade Serous Adenocarcinoma
1
Medulloblastoma
1
Glioma
1
Diffuse Intrinsic Pontine Glioma
1
Interventions
Temozolomide
3
Radiotherapy
3
TIC10 compound
2
Everolimus
2
spartalizumab
1
ribociclib
1
olutasidenib
1
lutetium Lu 177 dotatate
1
lorlatinib
1
larotrectinib
1
etoposide phosphate
1
balstilimab
1
Vaccines
1
Standard of Care
1
Specimen Handling
1
Proto-Oncogene Proteins c-akt
1
Phosphatidylinositol 3-Kinases
1
Ipilimumab
1
Injections
1
Immune Checkpoint Inhibitors
1
GDC-0084
1
Fluid Therapy
1
Etoposide
1
Eflornithine
1
Diphtheria-Tetanus Vaccine
1
Cetuximab
1
CBLC137
1
Biopsy
1
Bevacizumab
1
Automobiles
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Diffuse Intrinsic Pontine Glioma
×
Atovaquone
×
Clear all
NCT06624371
2025-07-22
AflacBT2303
Emory University
Phase 1
Recruiting
18 enrolled